Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 89801657 | 8980165 | 7 | F | 20160725 | 20121221 | 20160801 | EXP | PHHY2012BR115600 | NOVARTIS | 0.00 | F | Y | 63.00000 | KG | 20160801 | CN | COUNTRY NOT SPECIFIED | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 89801657 | 8980165 | 1 | PS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 20 MG, QMO (EVERY 28 DAYS) | 092414/S0144 | 21008 | 20 | MG | VIAL | /month | |||||
| 89801657 | 8980165 | 2 | C | AMLODIPIN | AMLODIPINE BESYLATE | 1 | Oral | 1 DF, QD (IN THE MORNING) | 0 | 1 | DF | TABLET | QD | ||||||
| 89801657 | 8980165 | 3 | C | LOSARTAN. | LOSARTAN | 1 | Unknown | 25 MG, QD | 0 | 25 | MG | QD | |||||||
| 89801657 | 8980165 | 4 | C | CARVEDILOL. | CARVEDILOL | 1 | Oral | 1 DF, QD | 0 | 1 | DF | TABLET | QD | ||||||
| 89801657 | 8980165 | 5 | C | SODIUM ALENDRONATE | 2 | Unknown | 70 MG, WEEKLY | 0 | 70 | MG | |||||||||
| 89801657 | 8980165 | 6 | C | CALCIUM CARBONATE/VITAMIN D3 | CALCIUM CARBONATECHOLECALCIFEROL | 1 | Oral | 1 DF, QD | 0 | 1 | DF | TABLET | QD | ||||||
| 89801657 | 8980165 | 7 | C | DIPYRONE | DIPYRONE | 1 | Oral | 40 DRP, PRN | U | U | 0 | 40 | GTT | ||||||
| 89801657 | 8980165 | 8 | C | DORFLEX | CAFFEINEDIPYRONEORPHENADRINE | 1 | Unknown | 1 DF, PRN | U | U | 0 | 1 | DF | ||||||
| 89801657 | 8980165 | 9 | C | DORFLEX | CAFFEINEDIPYRONEORPHENADRINE | 1 | U | U | 0 | ||||||||||
| 89801657 | 8980165 | 10 | C | ARADOIS | LOSARTAN POTASSIUM | 1 | Oral | 1 DF, QD | 0 | 1 | DF | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 89801657 | 8980165 | 1 | Acromegaly |
| 89801657 | 8980165 | 2 | Hypertension |
| 89801657 | 8980165 | 3 | Cardiac disorder |
| 89801657 | 8980165 | 4 | Cardiac disorder |
| 89801657 | 8980165 | 5 | Osteoporosis |
| 89801657 | 8980165 | 6 | Osteoporosis |
| 89801657 | 8980165 | 7 | Product used for unknown indication |
| 89801657 | 8980165 | 8 | Headache |
| 89801657 | 8980165 | 9 | Pain in extremity |
| 89801657 | 8980165 | 10 | Cardiac disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 89801657 | 8980165 | HO |
| 89801657 | 8980165 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 89801657 | 8980165 | Alopecia | |
| 89801657 | 8980165 | Angina pectoris | |
| 89801657 | 8980165 | Bradycardia | |
| 89801657 | 8980165 | Burning sensation | |
| 89801657 | 8980165 | Cough | |
| 89801657 | 8980165 | Dust allergy | |
| 89801657 | 8980165 | Fatigue | |
| 89801657 | 8980165 | Procedural pain | |
| 89801657 | 8980165 | Rhinorrhoea | |
| 89801657 | 8980165 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 89801657 | 8980165 | 1 | 201206 | 0 |